Avilar Therapeutics is a startup based in the United States.
Based in the United States, Avilar Therapeutics is a startup.
Avilar Therapeutics is a biopharmaceutical company developing extracellular protein degraders called ATACs (ASGPR Targeting Chimeras) that shuttle disease-causing circulating proteins to the endolysosome for degradation. The company is advancing a pipeline of therapeutics based on this extracellular protein degradation modality.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.